Todd Thomson
Board Member
Actuate Therapeutics, Inc. (ACTU)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Todd Thomson
Todd Thomson is recorded as Board Member at Actuate Therapeutics, Inc. (ACTU). Dragonfly Energy Holdings Corp. reported in an 8-K filed October 11, 2022 that Todd Thomson resigned as Resigning Director, effective October 4, 2022. Dragonfly Energy Holdings Corp. reported in an 8-K filed October 11, 2022 that Todd Thomson resigned as director, effective October 7, 2022.
“Todd Thomson Resigning Director”
“In connection with the Closing, Kerry Propper, Jonas Grossman, Alex Weil, Jonathan Biele, Roderick Hardamon, Jory Des Jardins, Hitesh Thakrar and Todd Thomson resigned as directors of Chardan”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Actuate Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel M. Schmitt CEO, Board Member
- Paul Lytle CFO
- Andrew P. Mazar COO
- Aaron G.L. Fletcher Board Member
- Amy Ronneberg Board Member
- Dr. Dan Zabrowski Board Member
- Dr. Roger Sawhney Board Member
- Jason Keyes Board Member
- Martin H. Huber, MD Board Member
- Roger Sawhney Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.